Bj. Gaynor et al., INHIBITION OF CHOLESTERYL ESTER TRANSFER PROTEIN-ACTIVITY IN HAMSTERSALTERS HDL LIPID-COMPOSITION, Atherosclerosis, 110(1), 1994, pp. 101-109
We investigated the role of cholesteryl ester transfer protein (CETP)
in hamsters by using a monoclonal antibody (MAb) that inhibited hamste
r CETP activity. MAbs were prepared against partially purified human C
ETP and screened for inhibition of H-3-cholesteryl oleate (CE) transfe
r from LDL to HDL in the presence of human plasma bottom fraction (d >
1.21 g/ml). Antibody 1C4 inhibited CE transfer activity in both human
plasma bottom fraction (IC50 = similar to 4 mu g/ml) and in whole pla
sma from male Golden Syrian hamsters (IC50 = similar to 30 mu g/ml). P
urified MAb 1C4 was injected into chow- and cholesterol-fed hamsters,
and blood was collected for analysis of plasma CETP activity and HDL l
ipid composition. Plasma CETP activity was inhibited by 70%-80% at all
times up to 24 h following injection of 500 mu g MAb 1C4 (similar to
3.7 mg/kg). The amount of antibody required for 50% inhibition at 24 h
post-injection was 200 mu g (similar to 1.5 mg/kg). Inhibition of ham
ster CETP activity in vivo increased hamster HDL cholesterol by 33% (P
< 0.0001), increased HDL-CE by 31% (P < 0.0001) and decreased HDL-tri
glyceride by 42% (P < 0.0001) (n = 36) as determined following isolati
on of HDL by ultracentrifugation. An increase in HDL cholesterol and a
redistribution of cholesterol to a larger HDL particle were also obse
rved following fast protein liquid chromatography (FPLC) gel filtratio
n of plasma lipoproteins. These results demonstrate that inhibition of
CETP activity in hamsters alters HDL lipid composition and particle s
ize and further demonstrate the utility of hamsters as a model for CET
P inhibition.